medigraphic.com
Instituto Nacional de Salud Pública

2015, Number 5

<< Back Next >>

salud publica mex 2015; 57 (5)

Global health 2035: a world converging within a generation.

Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, Bustreo F, Evans D, Feachem RGA, Frenk J, Ghosh G, Goldie SJ, Guo Y, Gupta S, Horton R, Kruk ME, Mahmoud A, Mohohlo LK, Ncube M, Pablos-Mendez A, Reddy KS, Saxenian H, Soucat A, Ulltveit-Moe KH, Yamey G

Language: Spanish
References: 54
Page: 444-467
PDF size: 371.84 Kb.


ABSTRACT

Prompted by the 20th anniversary of the 1993 World Development Report, a Lancet Commission revisited the case for investment in health and developed a new investment framework to achieve dramatic health gains by 2035. The Commission’s report has four key messages, each accompanied by opportunities for action by national governments of low-income and middle-income countries and by the international community. First, there is an enormous economic payoff from investing in health. The impressive returns make a strong case for both increased domestic financing of health and for allocating a higher proportion of official development assistance to development of health. Second, modeling by the Commission found that a “grand convergence” in health is achievable by 2035—that is, a reduction in infectious, maternal, and child mortality down to universally low levels. Convergence would require aggressive scale up of existing and new health tools, and it could mostly be financed from the expected economic growth of low- and middle-income countries. The international community can best support convergence by funding the development and delivery of new health technologies and by curbing antibiotic resistance. Third, fiscal policies —such as taxation of tobacco and alcohol— are a powerful and underused lever that governments can use to curb non-communicable diseases and injuries while also raising revenue for health. International action on NCDs and injuries should focus on providing technical assistance on fiscal policies, regional cooperation on tobacco, and funding policy and implementation research on scaling-up of interventions to tackle these conditions. Fourth, progressive universalism, a pathway to universal health coverage (UHC) that includes the poor from the outset, is an efficient way to achieve health and financial risk protection. For national governments, progressive universalism would yield high health gains per dollar spent and poor people would gain the most in terms of health and financial protection. The international community can best support countries to implement progressive UHC by financing policy and implementation research, such as on the mechanics of designing and implementing evolution of the benefits package as the resource envelope for public finance grows.


REFERENCES

  1. World Bank. World development Report [monografía de internet]. 1993 [consultado en febrero de 2013].Disponible en: http://files.dcp2.org/pdf/ WorldDevelopmentReport1993.pdf

  2. Institute for Health Metrics and Evaluation. Financing global health 2012: the end of the golden age?[monografía de internet] [consultado en febrero de 2013). Disponible en: http://healthmetricsandevaluation.org/ publications/policy-report/financing-global-health-2012-end-golden-age

  3. 3.Vallin J, Mesle F. The segmented trend line of highest life expectancies. Popul Dev Review 2009; 35:159-187.

  4. United Nations Development Programme. Human Development Report 2013. The rise of the south: human progress in a diverse world. Nueva York: United Nations Development Programme, 2013.

  5. Feachem RGA, Kjellstrom T, Murray CJL, Over M, Phillips MA, comps. The health of adults in the developing world. Nueva York: Oxford University Press, 1992.

  6. Bobadilla JL, Frenk J, Lozano R, Frejka T, Stern C. The epidemiological transition and health priorities. En: Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, comps. Disease control priorities in developing countries, Nueva York: Oxford University Press, 1993: 51-63.

  7. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health Aff 2007; 26: 972-983.

  8. Clements B, Coady D, Gupta S, comps. The economics of public healthcare reform in advanced and emerging economies. Washington, DC: International Monetary Fund 2012. [consultado en abril de 2013]. Disponible en: http://www.imf.org/external/pubs/ft/books/2012/health/healthcare.pdf

  9. Bloom DE, Canning D. Policy forum: public health. The health and wealth of nations. Science 2000; 287: 1207-1209.

  10. Bloom DE, Fink G. The economic case for devoting public resources to health. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, comps. Manson’s Tropical Diseases, 23ª ed. Filadelfia, PA: Saunders (en prensa).

  11. Thomas D, Frankenberg E. Health, nutrition and prosperity: a microeconomic perspective. Bull World Health Organ 2002; 80: 106-113.

  12. Strauss J, Thomas D. Health, nutrition, and economic development. J Econ Lit 1998; 36: 766-817.

  13. Bloom DE, Canning D, Jamison DT. Health, wealth, and welfare. Finance Dev 2004; 41: 10-115.

  14. Bloom DE, Sachs JD. Geography, demography, and economic growth in Africa. Brookings Pap Econ Act 1998; 2: 207-295.

  15. Jamison DT, Lau LJ, Wang J. Health’s contribution to economic growth in an environment of partially endogenous technical progress. En: Lopez- Casasnovas G, Rivera B, Currais L, comps. Health and economic growth: findings and policy implications. Cambridge, MA: The MIT Press, 2005: 67-91.

  16. Usher D. An imputation to the measure of economic growth for changes in life expectancy. En: Moss M, comp. The measurement of econo- mic and social performance. Nueva York: Columbia University Press for National Bureau of Economic Research, 1973.

  17. Williamson JG. British mortality and the value of life, 1781-1931. Popul Stud 1984; 38: 157-172.

  18. Nordhaus W. The health of nations: the contribution of improved health to living standards. En: Murphy K, Topel R, comps. Measuring the gains from medical research: an economic approach. Chicago: University of Chicago Press, 2003: 9-40.

  19. Bourguignon F, Morrisson C. Inequality among world citizens: 1820- 1992. Am Econ Rev 2002; 92: 727-744.

  20. Arrow K, Dasgupta P, Goulder LH, Mumford KJ, Oleson K. Sustainability and the measurement of wealth. Environ Dev Econ 2012; 17: 317-353.

  21. Sepúlveda J, Bustreo F, Tapia R, Rivera J, Lozano R, Oláiz G, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006;369; 368:2017-2027.

  22. WHO. Everybody’s business: strengthening health systems to improve health outcomes: WHO’s framework for action. Ginebra: World Health Organization, 2007.

  23. Kruk ME, Porignon D, Rockers PC, Van Lerberghe W. The contribution of primary care to health and health systems in low- and middle-income countries: a critical review of major primary care initiatives. Soc Sci Med 2010; 70:904-911.

  24. Rabkin M, Kruk ME, El-Sadr WM. HIV, aging and continuity of care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS 2012; 26 (Suppl 1): S77-S83.

  25. Croghan TW, Beatty A, Ron A. Routes to better health for children in four developing countries. Milbank Q 2006; 84: 333-358.

  26. Chisholm D, Naci H, Hyder AA, Tran NT, Peden M. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2011; 343: d5747.

  27. Organización Mundial de la Salud. Estadísticas mundiales de salud. 2013 [consultado en octubre de 2013]. Disponible en: http://apps.who.int/gho/ data/node.main.1?lang=eng

  28. Norheim OF. Estimated impact on life expectancy and mortality inequality of reducing under-five, maternal, tuberculosis and HIV mortality to a level comparable with four well-performing countries (China, Chile, Costa Rica, and Cuba). Documento de la Commission on Investing in Health, 2013 [consultado en octubre de 2013]. Disponible en: http:/globalhealth2035. org

  29. Taskforce on Innovative International Financing for Health Systems. Constraints to scaling up and costs: working group 1 report. Ginebra: International Health Partnership, 2009.

  30. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, and the Investment Framework Study Group. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011;377:2031-2041.

  31. Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I, Black RE, Lancet Diarrhoea and Pneumonia Interventions Study Group. Interventions to address deaths from childhood pneumonia and diarrhoea equitability: what works at what cost? Lancet 2013;381:1471-1429.

  32. The International Health Partnership. OneHealth Tool. [monografía en internet] [consultado en abril de 2013]. Disponible en: http://www. internationalhealthpartnership.net/en/tools/one-health-tool/

  33. Jamison DT, Sandbu M, Wang J. Why has infant mortality decreased at such different rates in different countries? Working paper no. 21. Bethesda: Disease Control Priorities Project, 2004.

  34. Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, and the Lancet NCD Action Group. Inequialities in non-communicable diseases and effective responses. Lancet 2013;381:585-597.

  35. WHO. Scaling up action against noncommunicable diseases: how much will it cost? [monografía en internet]. 2011 [consultado en octubre de 2013]. Disponible en: http://www.who.int/nmh/publications/cost_of_inaction/ en/

  36. WHO. Prevention and control of NCDs: priorities for investment. Discussion paper for the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control. Geneva: World Health Organization, 2011.

  37. Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control 2012; 21:172-180.

  38. Nelson TF, Xuan Z, Babor TF, Brewer RD, Chaloupka FJ, Gruenewald PJ, et al. Efficacity and the strength of evidence of U.S. alcohol control policies. Am J Prev Med 2013;45:19-28.

  39. Jou J, Techakehakij W. International application of sugar-sweetened beverage (SSB) taxation in obesity reduction: factors that may influence policy effectiveness in country-specific contexts. Health Policy 2012; 107: 83-90.

  40. Aldy JE. Designing energy and environmental fiscal instruments to improve public health. Commission on Investing in Health Working Paper, 2013. [consultado en octubre de 2013]. Disponible en: http://globalhealth2035. org

  41. WHO. World report on road traffic injury prevention, 2004. Ginebra: World Health Organization, 2004.

  42. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, et al. Suicide prevention stategies: a systematic review. JAMA 2005;294:2064-2074.

  43. Mozaffarian D, Stampfer MJ. Removing industrial trans fat from foods. BMJ 2010; 340: c1826.

  44. Rodgers A, Patel A, Berwanger O, Bots M, Grimm R, Grobbee DE, and the PILL Collaborative Group. An international randomised pracebo-controlled trial of a four-component combination pill (“polypill”) in people with raised cardiovascular risk. PLoS One 2011;6:e19857.

  45. Africa Progress Panel. 2013 Africa Progress Report—equity in extractives: stewarding Africa’s natural resources for all. 2013 [consultado en octubre de 2013]. Disponible en: http://www.africaprogresspanel.org/en/ publications/africa-progress-report-2013/apr-documents/

  46. WHO. Macroeconomics and health: investing in health for economic development. Ginebra: World Health Organization, 2001.

  47. Gwatkin DR, Ergo A. Universal health coverage: friend or foe of equity? Lancet 2011; 377: 2160-2161.

  48. Sekhri N, Savedoff W. Regulating private health insurance to serve the public interest: policy issues for developing countries. Int J Health Plann Manage 2006; 21: 357-392.

  49. Pablos-Méndez A, Tabish H, de Ferranti D. The cost disease and global health. En: Baumol W, comp. The cost disease: why computers get cheaper and health care doesn’t. New Haven: Yale University Press, 2012: 94-108.

  50. World Bank. World Development Indicators 2013. Washington DC: World bank, 2013.

  51. Organisation for Economic Cooperation and Development. Health status. 2013 [consultado en octubre de 2013]. Disponible en: http://stats. oecd.org/index.aspx?DataSetCode=HEALTH_STAT

  52. Krivelli E, Leive A, Stratmann T. Subnational health spending and soft budget constraints in OECD countries. Documento de Trabajo del IMF 2010 [consultado en octubre de 2013]. Disponible en: http://www.imf.org/ external/pubs/ft/wp/2010/wp10147.pdf

  53. Feachem RGA, Sekhri NK, White KL. Getting more for their dollar: a comparison of the NHS with California’s Kaiser Permanente. BMJ 2002; 324: 135-141.

  54. Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet 2012; 380: 933-943.




2020     |     www.medigraphic.com